Senior director at Smith & Nephew plc
- Key drivers behind continued adoption of robotic-assisted knee reconstruction surgery, including clinical benefits and patient satisfaction
- Competitive dynamics across key players including Zimmer Biomet's (NYSE: ZBH) Rosa, Johnson & Johnson's (NYSE: JNJ) Velys and Stryker's (NYSE: SYK) Mako
- Shift in commercial agreements including volume commitments and benefits to tier 2 players
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.